Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1278 of 5804
-
AI helps surgeons spot skin cancer cells during surgery
Knowledge-focused Recruiting nowThe aim is to use AI to assist surgeons in analyzing CLSM tissue slide images obtained during BCC surgeries with the aim to integrate it in real time. We plan to use AI to analyze CLSM images of BCCs and distinguish between tumor tissue, inflammatory tissue, and non-tumor/non-inf…
Sponsor: LMU Klinikum • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:58 UTC
-
Garlic pills tested as shield against hospital superbugs
Prevention ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn if garlic tablets works to prevent nosocomial infections in hospitalized patients in ICU. The main questions it aims to answer are: Does garlic tablets administration lower the occurence of nosocomial infections in hospitalized patient…
Phase: PHASE3 • Sponsor: Alexandria University • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
Could pepcid and a skin lotion finally stop burn scar itching?
Symptom relief Recruiting nowThe purpose of the study is to see whether using diphenhydramine (Benadryl), famotidine (Pepcid), and cromolyn sodium will decrease burn scar itch.
Phase: PHASE3 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New drug hopes to ease breathing and heart strain in lung disease patients
Disease control Recruiting nowThe goal of this clinical trial is to see if mirivadelgat will work in patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD). It will also learn about the safety of mirivadelgat. The main question it aims to answer is if mirivadelgat will improve…
Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Poking skin to bring back color: which needle works best for vitiligo?
Disease control Recruiting nowThis randomized controlled trial aims to compare the efficacy of needling versus microneedling, both followed by narrowband UVB therapy, in achieving repigmentation in patients with localized stable non-segmental vitiligo.
Phase: PHASE4 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:18 UTC
-
Own cells implanted in brain to fight Parkinson's
Disease control OngoingThis clinical study is designed to explore the safety and tolerability of UX-DA001. It will also explore if UX-DA001 works to improve motor function in subjects with Parkinson's disease. UX-DA001 manufactured from participant's own cells will differentiate into mature dopaminergi…
Phase: PHASE1 • Sponsor: Shanghai UniXell Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could skipping the flap during radiation reduce side effects without harming cancer control?
Disease control Recruiting nowPatients with oral cavity cancer treated by reconstructive surgery with a flap. Patients will be treated in the study for : * Experimental arm: Post-operative radiotherapy with flap sparing * Control arm: Standard post-operative radiotherapy without flap sparing (current practi…
Phase: PHASE3 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Experimental cell therapy targets Hard-to-Treat nerve diseases
Disease control Recruiting nowThis study is a single-arm, open-label, non-randomized clinical trial aimed at evaluating the safety, tolerability and preliminary efficacy of CNCT19 cell injection in the treatment of patients with relapsed/refractory Neurological Autoimmune Diseases.
Phase: EARLY_PHASE1 • Sponsor: Juventas Cell Therapy Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New HOPE therapy aims to tackle opioid addiction and PTSD together
Symptom relief Recruiting nowThis study will test a therapy intervention, HOPE, for individuals with opioid use disorder and posttraumatic stress disorder. Interested individuals will need to be taking medications for opioid use disorder (e.g., suboxone, naltrexone, methadone). Interested participants will c…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
AI tool aims to speed up kawasaki disease diagnosis in kids
Diagnosis Recruiting nowEvaluating the impact of a machine-learning clinical decision support tool on provider practice when evaluating febrile patients with Kawasaki Disease (KD) and non-KD illnesses.
Phase: NA • Sponsor: University of California, San Diego • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Robot suit and video games aim to restore arm movement after stroke
Symptom relief Recruiting nowTwo decades ago, the projection of recovery of the upper extremity (UE) after a stroke had a very poor prognosis worldwide. Nowadays, thanks to medical advances and early rehabilitation, the prognosis for recovery has improved; however, there is still a limit that no therapy has …
Phase: NA • Sponsor: University of Chile • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
AI-Powered insulin dosing shows promise for diabetes control
Disease control CompletedThe goal of this clinical trial is to learn if an intelligent insulin-dosing decision support system can improve glycemic control in adults with type 2 diabetes who are starting basal insulin therapy. The trial also aims to evaluate the safety of using this system for insulin dos…
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
AI heart patch could slash stroke risk in rural seniors
Knowledge-focused Recruiting nowAbstract Purpose: Atrial fibrillation (AF) is a leading cause of stroke and heart failure, yet detection remains suboptimal in rural settings due to limited resources. This study evaluates whether an enhanced screening strategy using artificial intelligence (AI)-integrated 7-day …
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New sedative could be safer for frail patients during medical procedures
Symptom relief OngoingRemimazolam is a new, ultra-short-acting benzodiazepine approved in Romania for procedural sedation. It shows significant clinical benefits compared to other sedatives like Propofol or Midazolam, especially in elderly or high-risk patients. Advantages include better hemodynamic s…
Phase: PHASE4 • Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Uterine scarring breakthrough? 5,000-Woman study tests new surgery and stent
Disease control Recruiting nowThis research plan aims to explore a new diagnosis and treatment management model for intrauterine adhesions and verify its efficacy and feasibility through a multicenter real-world study. Intrauterine adhesions are a common gynecological disease that may affect women's fertility…
Phase: NA • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Groundwork laid for lifesaving GBS vaccine trials in africa
Knowledge-focused Recruiting nowInfections are one of the key causes of newborn deaths. Among them, Group B Streptococcus (GBS) is the leading cause of sepsis and bacterial meningitis in the first 90 days of life. Fortunately, GBS vaccines for pregnant women, a powerful tool for fighting infections, are curren…
Sponsor: Barcelona Institute for Global Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Freezing heart plaque: a new hope for artery health?
Disease control Recruiting nowICECAP is a multi-centre, prospective, single-arm, interventional, traditional feasibility clinical investigation to evaluate the efficacy and safety of intra-coronary cryotherapy on vulnerable or high-risk plaque (HRP), using the CryoTherapy System (CTS). The study aims to enrol…
Phase: NA • Sponsor: Cryotherapeutics SA • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a common diabetes drug shield hearts from AF-Related failure?
Disease control Recruiting nowHeart failure is the most important clinical endpoint event in atrial fibrillation (AF). Patients with AF complicated by heart failure have a significantly higher risk of all-cause mortality and cardiovascular mortality compared to those without heart failure. Abnormal left atria…
Phase: PHASE2 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can a One-Two punch tame overgrown wound tissue?
Disease control TerminatedThis randomized controlled trial aims to compare the efficacy of silver nitrate, triamcinolone, and a successive use of both treatments in managing hypergranulation tissue in traumatic wounds. Conducted over a four-year period at UPMC Mercy, the study will involve patients presen…
Phase: PHASE2, PHASE3 • Sponsor: Francesco Egro • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
AI reads blood flow to predict if heart stents will work
Knowledge-focused Recruiting nowThe primary aim of this study is to evaluate changes in absolute coronary flow and pressure before and after percutaneous coronary intervention in calcified lesions. The secondary aim is to use a machine learning model to predict the outcome of the intervention.
Sponsor: Aalborg University Hospital • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC